Pharmaceutical Excipients Global Market - Forecast to 2025

Publishing Date : July, 2019
Report Code : HCPH 0102
Price:
Single license $4,950
Site license $6,750
Global license $9,000


 

Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability, and stability of active substances for formulating final drug dosage forms. The excipients form the major part in any medicinal product and proportion of it when compared to Active Pharmaceutical Ingredient (API) exceeds two to three folds in any pharmaceutical preparations. Hence, various characteristics such as functionality, regulatory status, sources, cost, consistency, bioavailability, physicochemical properties, stability, and pharmacokinetic parameters, etc. play a major role in determining the suitability of a substance as an excipient.

As estimated by IQ4I Research, the pharmaceutical excipients global market is expected to grow at a single digit CAGR from 2018 to 2025 to reach $9,911.2 million by 2025. The pharmaceutical excipients market is segmented by source, products, process, functionality, drug dosage forms and finished products.

Pharmaceutical excipients market by the source is segmented as animal-based, plant-based, mineral-based and synthetic based excipients. Plant-based excipients held the highest revenue in 2018 and it is a fastest growing segment at a high single digit CAGR from 2018 to 2025, due to plant-based excipients are cost-effective, low toxic with the better patient tolerance, bio-compatible and they are easily available. By-products, excipients are segmented into inorganic chemicals, organic chemicals and pharmaceutical water. The organic chemicals segment held the highest revenue in 2018 and it is expected to grow at a single digit CAGR from 2018 to 2025, due to the use of these excipients in majorly all of the pharmaceutical formulations as they offer advantages such as increased efficacy in oral delivery of poorly soluble molecules along with increased compressibility and flowability properties.

Inorganic chemical excipients market by type, are further divided into calcium salts, halites, metallic oxides, silicates, and other inorganic chemicals, among which metallic oxides held a major revenue in 2018 and Calcium salts segment is expected to grow at a high single digit CAGR from 2018 to 2025. Calcium salts are further sub-segmented into calcium phosphate and calcium carbonate, among which calcium phosphate held the highest revenue in 2018 and calcium carbonate segment is expected to grow at a high single digit CAGR from 2018 to 2025. Calcium carbonate is further classified into GCC and PCC, among which PCC held the highest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025. Metallic oxides segment are further segmented into titanium dioxide and Others (Iron Oxide, Magnesium Oxide & Aluminum Hydroxide). Titanium Dioxide held the highest revenue in 2018 and it is expected to grow at a mid single digit CAGR from 2018 to 2025.

Organic chemical excipients market by type is further divided into carbohydrates, petrochemicals, oleochemicals, proteins, and other organic chemicals. Oleochemicals held major revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025.

Carbohydrate excipients market by type is further segmented into sugar, starch, and cellulose, among which sugar held the largest revenue in 2018 and expected to grow at a mid single digit CAGR from 2018 to 2025. Sugar segment is further divided into actual sugar, sugar alcohol, and artificial sweeteners, where actual sugar held the largest revenue in 2018 and sugar alcohol segment is expected to grow at a mid single digit CAGR from 2018 to 2025.

Actual sugar segment is further sub-segmented into lactose, sucrose, and dextrose, where lactose held the largest revenue in 2018 and dextrose segment is expected to grow at a mid single digit CAGR from 2018 to 2025. Sugar alcohol segment is further classified into sorbitol, mannitol and other sugar alcohols, where mannitol held the largest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025. The starch segment is further divided into modified starch, dried starch and converted starch, where modified starch held the largest revenue in 2018 and dried starch is expected to grow at a mid single digit CAGR from 2018 to 2025. Cellulose segment is further sub-segmented into cellulose ethers, cellulose esters, croscarmellose sodium, and microcrystalline cellulose, where cellulose ethers held the largest revenue in 2018 and microcrystalline cellulose is expected to grow at a mid single digit CAGR from 2018 to 2025.

Petrochemical excipients market by type is further segmented into glycols, povidones, mineral hydrocarbons, acrylic polymers, and other petrochemical excipients. Glycol held the largest revenue in 2018 and acrylic polymers is expected to grow at a high single digit CAGR from 2018 to 2025. Glycol segment is further segmented into Polyethylene Glycol and Propylene Glycol, where Polyethylene Glycol held the largest revenue in 2018 it is expected to grow at a mid single digit CAGR from 2018 to 2025.

Oleochemicals excipients market by type is further segmented into Fatty Alcohols, Metal stearates, Glycerin, and Other Oleochemical Excipients. Fatty Alcohol held the largest revenue in 2018 and Metal stearates is expected to grow at a high single digit CAGR from 2018 to 2025.

Pharma/USP water excipients market by type is further segment into the water for injections and purified water. Water for injections held the largest revenue in 2018 and it is expected to grow at a mid single digit CAGR from 2018 to 2025. Pharmaceutical excipients market by the process is segmented as granulation and direct compression. Granulation held the largest revenue in 2018 and direct compression is expected to grow at a high single digit CAGR from 2018 to 2025.

Pharmaceutical excipients market by functionality is segmented as preservatives, solvent, binders & adhesives, fillers & diluents, suspending agent, coatings, solubilizer, disintegrant, colorant, flavoring & sweeteners, lubricants & glidants, and others. Binders & Adhesives held the largest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025.

Pharmaceutical excipients market by dosage forms is segmented as solid dosage forms, injectables and semisolid, liquid and gaseous. Solid dosage forms held the largest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025. Some of the factors driving the market are solid dosage forms are cost-effective, solid dosage provides increased physical and chemical stability, controlled-release options, and superior ease of handling.

Pharmaceutical excipients market by finished products is segmented as Prescription drugs and OTC. Prescription drugs held the largest revenue in 2018 and it is expected to grow at a mid single digit CAGR from 2018 to 2025.

Pharmaceutical excipients market by region is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (China, India, Japan, and Others) and Rest of the world (Brazil, Rest of Latin America and Middle East & others). North America held the highest revenue in 2018, due to increasing demand for functional excipients, implementation of new novelties like nanotechnology, increasing usage of oral solid dosage forms, increasing incidence of chronic disorders, elderly population and favorable reimbursement scenario for drugs. Asia-Pacific is the fastest growing region with a high single digit CAGR from 2018 to 2025, due to increasing excipients outsourcing by companies, low manufacturing, and low labor costs, adopting modern innovations like nanotechnology, advancement in the development of functional excipients, rise in chronic diseases, growing generics market owing to patent cliffs, rising healthcare demand, better infrastructure, lower capital, and overhead costs. Excipients manufacturers in developing countries face major challenges to develop product with quality at an affordable price, due to lower price of excipients and large number of producers, which creates a price sensitive market. Some manufacturers may compromise the quality of product in order to keep prices low and boost sales, while some of the manufacturers having a larger market for their products, can sell their higher volume excipients at a slightly lower price.

Some of the key players contributing at global level for pharmaceutical excipients market growth are Dow DuPont (U.S.), Ashland, Inc. (U.S.), BASF SE (Germany), DFE Pharma (Germany), Evonik Industries AG (Germany), Associated British Foods Plc (U.K.), Merck KGAA (U.S.), Roquette (France), Colorcon (U.S.), and Asahi Kasei (Japan).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia-Pacific 
  • China
  • India
  • Japan
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East and Others

 

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.5     PRIMARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     GROWTH IN GENERICS AND BIOSIMILAR DRUGS
        • 3.3.1.2     INCREASING DEMAND FOR OSDF EXCIPIENTS
        • 3.3.1.3     INCREASING DEMAND FOR MULTIFUNCTIONAL EXCIPIENTS
        • 3.3.1.4     DRUG-COATED MEDICAL DEVICES
        • 3.3.1.5     INCREASED DEMAND FOR SOLUBILITY ENHANCING EXCIPIENTS
        • 3.3.1.6     RISING DEMAND FOR SUSTAINED OR CONTROLLED RELEASE FORMULATIONS
        • 3.3.1.7     NOVEL EXCIPIENTS FOR BIOLOGIC DRUGS
        • 3.3.1.8     INCREASING PREVALENCE OF CHRONIC DISEASES, RISE IN THE AGING POPULATION
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     ADVERSE REACTIONS OF EXCIPIENTS
        • 3.3.2.2     CONTAMINATION IN FORMULATIONS
        • 3.3.2.3     HIGH MARKET FRAGMENTATION WITH LOW-PROFIT MARGINS
        • 3.3.2.4     DEMAND FOR SAFE AND QUALITY EXCIPIENTS BY REGULATORY AUTHORITIES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
      • 3.4.2     INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL (IPEC FEDERATION)
      • 3.4.3     PHARMACEUTICAL QUALITY GROUP (PQG)
      • 3.4.4     U.S.
      • 3.4.5     EUROPE
      • 3.4.6     JAPAN
      • 3.4.7     CHINA
      • 3.4.8     INDIA
      • 3.4.9     REST OF THE WORLD
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     BARGAINING POWER OF SUPPLIERS
      • 3.5.4     BARGAINING POWER OF BUYERS
      • 3.5.5     COMPETITIVE RIVALRY
    • 3.6     SUPPLY CHAIN ANALYSIS
    • 3.7     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.7.1     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE ANALYSIS
    • 3.8     NOVEL EXCIPIENTS
    • 3.9     MOLECULE TYPE
    • 3.1     DRUG MASTER FILING (DMF)
    • 3.11     EXCIPIENTS BY MOLECULE TYPE
    • 3.12     EXCIPIENTS PRICING
    • 3.13     GLOBAL PHARMACEUTICAL EXCIPIENTS PRODUCTION VOLUME
    • 3.14     EXCIPIENTS USED IN GLOBAL TOP 100 SELLING DRUGS BY REVENUE
    • 3.15     EXCIPIENT MANUFACTURER’S REVENUE, PRODUCT, FUNCTIONALITY AND DOSAGE FORMS
  • 4     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY SOURCE
    • 4.1     INTRODUCTION
    • 4.2     ANIMAL BASED EXCIPIENTS
    • 4.3     PLANT BASED EXCIPIENTS
    • 4.4     MINERAL BASED EXCIPIENTS
    • 4.5     SYNTHETIC BASED EXCIPIENTS
  • 5     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY PRODUCT
    • 5.1     INTRODUCTION
    • 5.2     INORGANIC CHEMICALS
      • 5.2.1     CALCIUM SALTS
        • 5.2.1.1     CALCIUM PHOSPHATE
        • 5.2.1.2     CALCIUM CARBONATE
          • 5.2.1.2.1      GCC
          • 5.2.1.2.2      PCC
        • 5.2.1.3     OTHER CALCIUM SALT
      • 5.2.2     HALITES
      • 5.2.3     METALLIC OXIDES
        • 5.2.3.1     TITANIUM DIOXIDE
        • 5.2.3.2     OTHER METALLIC OXIDES
      • 5.2.4     SILICATES
      • 5.2.5     OTHER INORGANIC CHEMICALS
    • 5.3     ORGANIC CHEMICALS
      • 5.3.1     CARBOHYDRATES
        • 5.3.1.1     SUGAR
          • 5.3.1.1.1      ACTUAL SUGAR
            • 5.3.1.1.1.1      LACTOSE
            • 5.3.1.1.1.2      SUCROSE
            • 5.3.1.1.1.3      DEXTROSE
          • 5.3.1.1.2      SUGAR ALCOHOL
            • 5.3.1.1.2.1      SORBITOL
            • 5.3.1.1.2.2      MANNITOL
            • 5.3.1.1.2.3      OTHER SUGAR ALCOHOLS
          • 5.3.1.1.3      ARTIFICIAL SWEETENERS
        • 5.3.1.2     STARCH
          • 5.3.1.2.1      MODIFIED STARCH
          • 5.3.1.2.2      DRIED STARCH
          • 5.3.1.2.3      CONVERTED STARCH
        • 5.3.1.3     CELLULOSE
          • 5.3.1.3.1      CELLULOSE ETHERS
          • 5.3.1.3.2      CELLULOSE ESTERS
          • 5.3.1.3.3      CROSCARMELLOSE SODIUM
          • 5.3.1.3.4      MICROCRYSTALLINE CELLULOSE
      • 5.3.2     PETROCHEMICALS
        • 5.3.2.1     GLYCOL
          • 5.3.2.1.1      POLYETHYLENE GLYCOL
          • 5.3.2.1.2      PROPYLENE GLYCOL
        • 5.3.2.2     POVIDONES
        • 5.3.2.3     MINERAL HYDROCARBONS
          • 5.3.2.3.1      PETROLATUM
          • 5.3.2.3.2      MINERAL WAXES
          • 5.3.2.3.3      MINERAL OILS
        • 5.3.2.4     ACRYLIC POLYMERS
        • 5.3.2.5     OTHER PETROCHEMICALS
      • 5.3.3     OLEOCHEMICALS
        • 5.3.3.1     FATTY ALCOHOLS
        • 5.3.3.2     METAL STEARATES
        • 5.3.3.3     GLYCERIN
        • 5.3.3.4     OTHER OLEOCHEMICALS
      • 5.3.4     PROTEINS
      • 5.3.5     OTHER ORGANIC CHEMICALS
    • 5.4     PHARMA/USP WATER
      • 5.4.1     WATER FOR INJECTION
      • 5.4.2     PURIFIED WATER
  • 6     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY MANUFACTURING PROCESS
    • 6.1     INTRODUCTION
    • 6.2     GRANULATION
    • 6.3     DIRECT COMPRESSION
  • 7     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY FUNCTIONALITY
    • 7.1     INTRODUCTION
    • 7.2     PRESERVATIVES
    • 7.3     SOLVENT
    • 7.4     BINDERS & ADHESIVES
    • 7.5     FILLERS & DILUENTS
    • 7.6     SUSPENDING AGENT
    • 7.7     COATINGS
    • 7.8     SOLUBILIZERS
    • 7.9     DISINTEGRANT
    • 7.10     COLORANT, FLAVOURING & SWEETENERS
    • 7.11     LUBRICANTS & GLIDANTS
    • 7.12     OTHERS
  • 8     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY DOSAGE FORMS
    • 8.1     INTRODUCTION
    • 8.2     SOLID DOSAGE FORMS
    • 8.3     INJECTABLES
    • 8.4     SEMISOLID, LIQUID AND GASEOUS
  • 9     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY FINISHED PRODUCTS
    • 9.1     INTRODUCTION
    • 9.2     PRESCRIPTION DRUGS
    • 9.3     OVER-THE-COUNTER (OTC) DRUGS
  • 10     REGIONAL ANALYSIS
    • 10.1     INTRODUCTION
    • 10.2     NORTH AMERICA
      • 10.2.1     U.S.
      • 10.2.2     REST OF NORTH AMERICA
    • 10.3     EUROPE
      • 10.3.1     GERMANY
      • 10.3.2     FRANCE
      • 10.3.3     ITALY
      • 10.3.4     REST OF EUROPE
    • 10.4     APAC
      • 10.4.1     CHINA
      • 10.4.2     INDIA
      • 10.4.3     JAPAN
      • 10.4.4     REST OF APAC
    • 10.5     ROW
      • 10.5.1     BRAZIL
      • 10.5.2     REST OF LATAM
      • 10.5.3     MIDDLE EAST & OTHERS
  • 11     COMPETITIVE LANDSCAPE
    • 11.1     INTRODUCTION
    • 11.2     NEW PRODUCT LAUNCHES
    • 11.3     ACQUISITION
    • 11.4     AGREEMENTS, COLLABORATION & JOINT VENTURES
  • 12     MAJOR COMPANIES
    • 12.1     ASAHI KASEI
      • 12.1.1     OVERVIEW
      • 12.1.2     FINANCIALS
      • 12.1.3     PRODUCT PORTFOLIO
      • 12.1.4     KEY DEVELOPMENTS
      • 12.1.5     BUSINESS STRATEGY
      • 12.1.6     SWOT ANALYSIS
    • 12.2     ASHLAND, INC
      • 12.2.1     OVERVIEW
      • 12.2.2     FINANCIALS
      • 12.2.3     PRODUCT PORTFOLIO
      • 12.2.4     KEY DEVELOPMENTS
      • 12.2.5     BUSINESS STRATEGY
      • 12.2.6     SWOT ANALYSIS
    • 12.3     ASSOCIATED BRITISH FOODS PLC (SPI PHARMA)
      • 12.3.1     OVERVIEW
      • 12.3.2     FINANCIALS
      • 12.3.3     PRODUCT PORTFOLIO
      • 12.3.4     KEY DEVELOPMENTS
      • 12.3.5     BUSINESS STRATEGY
      • 12.3.6     SWOT ANALYSIS
    • 12.4     AVANTOR INC
      • 12.4.1     OVERVIEW
      • 12.4.2     FINANCIALS
      • 12.4.3     PRODUCT PORTFOLIO
      • 12.4.4     KEY DEVELOPMENTS
      • 12.4.5     BUSINESS STRATEGY
      • 12.4.6     SWOT ANALYSIS
    • 12.5     BASF SE
      • 12.5.1     OVERVIEW
      • 12.5.2     FINANCIALS
      • 12.5.3     PRODUCT PORTFOLIO
      • 12.5.4     KEY DEVELOPMENTS
      • 12.5.5     BUSINESS STRATEGY
      • 12.5.6     SWOT ANALYSIS
    • 12.6     COLORCON, INC.
      • 12.6.1     OVERVIEW
      • 12.6.2     FINANCIALS
      • 12.6.3     PRODUCT PORTFOLIO
      • 12.6.4     KEY DEVELOPMENTS
      • 12.6.5     BUSINESS STRATEGY
      • 12.6.6     SWOT ANALYSIS
    • 12.7     CRODA INTERNATIONAL PLC
      • 12.7.1     OVERVIEW
      • 12.7.2     FINANCIALS
      • 12.7.3     PRODUCT PORTFOLIO
      • 12.7.4     KEY DEVELOPMENTS
      • 12.7.5     BUSINESS STRATEGY
      • 12.7.6     SWOT ANALYSIS
    • 12.8     DFE PHARMA
      • 12.8.1     OVERVIEW
      • 12.8.2     FINANCIALS
      • 12.8.3     PRODUCT PORTFOLIO
      • 12.8.4     KEY DEVELOPMENTS
      • 12.8.5     BUSINESS STRATEGY
      • 12.8.6     SWOT ANALYSIS
    • 12.9     DOW DUPONT INC.
      • 12.9.1     OVERVIEW
      • 12.9.2     FINANCIALS
      • 12.9.3     PRODUCT PORTFOLIO
      • 12.9.4     KEY DEVELOPMENTS
      • 12.9.5     BUSINESS STRATEGY
      • 12.9.6     SWOT ANALYSIS
    • 12.10     EVONIK INDUSTRIES AG
      • 12.10.1     OVERVIEW
      • 12.10.2     FINANCIALS
      • 12.10.3     PRODUCT PORTFOLIO
      • 12.10.4     KEY DEVELOPMENTS
      • 12.10.5     BUSINESS STRATEGY
      • 12.10.6     SWOT ANALYSIS
    • 12.11     LUBRIZOL CORPORATION
      • 12.11.1     OVERVIEW
      • 12.11.2     FINANCIALS
      • 12.11.3     PRODUCT PORTFOLIO
      • 12.11.4     KEY DEVELOPMENTS
      • 12.11.5     BUSINESS STRATEGY
      • 12.11.6     SWOT ANALYSIS
    • 12.12     MERCK KGAA
      • 12.12.1     OVERVIEW
      • 12.12.2     FINANCIALS
      • 12.12.3     PRODUCT PORTFOLIO
      • 12.12.4     KEY DEVELOPMENTS
      • 12.12.5     BUSINESS STRATEGY
      • 12.12.6     SWOT ANALYSIS
    • 12.13     ROQUETTE FRÈRES S.A.
      • 12.13.1     OVERVIEW
      • 12.13.2     FINANCIALS
      • 12.13.3     PRODUCT PORTFOLIO
      • 12.13.4     KEY DEVELOPMENTS
      • 12.13.5     BUSINESS STRATEGY
      • 12.13.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 2     EXCIPIENTS PRICING
      • TABLE 3     GLOBAL PHARMACEUTICAL EXCIPIENTS REVENUE ($MN), AVERAGE SELLING PRICE ($/KG) AND PRODUCTION IN TONS, BY PRODUCT (2018)
      • TABLE 4     GLOBAL PHARMACEUTICAL EXCIPIENTS PRODUCTION, BY PRODUCT, (2017-2025) (TONS)
      • TABLE 5     EXCIPIENTS USED IN GLOBAL TOP SELLING DRUGS (2017)
      • TABLE 6     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 7     ANIMAL BASED EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 8     PLANT BASED EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 9     MINERAL BASED EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 10     SYNTHETIC BASED EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 11     GLOBAL PHARMACEUTICAL EXCIPIENTS PRODUCTION, BY PRODUCT, (2017-2025) (TONS)
      • TABLE 12     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 13     GLOBAL INORGANIC CHEMICAL EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 14     INORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 15     INORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 16     GLOBAL CALCIUM SALTS EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 17     CALCIUM SALTS EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 18     CALCIUM SALTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 19     CALCIUM PHOSPHATE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 20     GLOBAL CALCIUM CARBONATE EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 21     CALCIUM CARBONATE EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 22     CALCIUM CARBONATE GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 23     GCC GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 24     PCC GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 25     OTHER CALCIUM SALTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 26     HALITES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 27     GLOBAL METALLIC OXIDE EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 28     METALLIC OXIDE EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 29     METALLIC OXIDE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 30     TITANIUM DIOXIDE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 31     OTHER METALLIC OXIDES EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 32     SILICATES EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 33     OTHER INORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 34     GLOBAL ORGANIC CHEMICAL EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 35     ORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 36     ORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE,BY REGION, (2017-2025) ($MN)
      • TABLE 37     GLOBAL CARBOHYDRATE EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 38     CARBOHYDRATE EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 39     CARBOHYDRATE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 40     GLOBAL SUGAR EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 41     SUGAR EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 42     SUGAR EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 43     GLOBAL ACTUAL SUGAR EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 44     ACTUAL SUGAR EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 45     ACTUAL SUGAR EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 46     LACTOSE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 47     SUCROSE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 48     DEXTROSE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 49     GLOBAL SUGAR ALCOHOL EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 50     SUGAR ALCOHOL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 51     SUGAR ALCOHOL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 52     SORBITOL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 53     MANNITOL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 54     OTHER SUGAR ALCOHOL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 55     ARTIFICIAL SWEETENER EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 56     GLOBAL STARCH EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 57     STARCH EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 58     STARCH EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 59     MODIFIED STARCH EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 60     DRIED STARCH EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 61     CONVERTED STARCH EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 62     GLOBAL CELLULOSE EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 63     CELLULOSE EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) (TONS)
      • TABLE 64     CELLULOSE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 65     CELLULOSE ETHERS EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 66     CELLULOSE ESTERS EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 67     CROSCARMELLOSE SODIUM EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 68     MICROCRYSTALLINE CELLULOSE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 69     GLOBAL PETROCHEMICAL EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 70     PETROCHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 71     PETROCHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 72     GLYCOL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 73     GLYCOL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 74     POLYETHYLENE GLYCOL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 75     PROPYLENE GLYCOL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 76     POVIDONES EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 77     MINERAL HYDROCARBONS EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 78     ACRYLIC POLYMERS EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 79     OTHER PETROCHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 80     GLOBAL OLEOCHEMICAL EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 81     OLEOCHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 82     OLEOCHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 83     FATTY ALCOHOLS EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 84     METAL STEARATE EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 85     GLYCERIN EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 86     OTHER OLEOCHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 87     PROTEIN EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 88     OTHER ORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 89     GLOBAL PHARMA/USP WATER EXCIPIENTS PRODUCTION, BY TYPE, (2017-2025) (TONS)
      • TABLE 90     PHARMA/USP WATER EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 91     PHARMA/USP WATER EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 92     WATER FOR INJECTION EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 93     PURIFIED WATER EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 94     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE,BY MANUFACTURING PROCESS, (2017-2025) ($MN)
      • TABLE 95     GRANULATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 96     DIRECT COMPRESSION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 97     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY FUNCTIONALITY, (2017-2025) ($MN)
      • TABLE 98     PRESERVATIVES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 99     SOLVENT GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 100     BINDER & ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 101     FILLERS & DILUENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 102     SUSPENDING AGENT GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 103     COATINGS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 104     SOLUBILIZER GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 105     DISINTEGRANT GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 106     COLORANT, FLAVOURING & SWEETENERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 107     LUBRICANT & GLIDANTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 108     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 109     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY DOSAGE FORMS, (2017-2025) ($MN)
      • TABLE 110     SOLID DOSAGE FORMS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 111     INJECTABLES DOSAGE FORM GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 112     SEMISOLID, LIQUID AND GASEOUS DOSAGE FORMS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 113     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY FINISHED PRODUCTS, (2017-2025) ($MN)
      • TABLE 114     PRESCRIPTION DRUGS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 115     OTC DRUGS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 116     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 117     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 118     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 119     NORTH AMERICA INORGANIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 120     NORTH AMERICA CALCIUM SALTS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 121     NORTH AMERICA CALCIUM CARBONATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 122     NORTH AMERICA METAL OXIDES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 123     NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 124     NORTH AMERICA CARBOHYDRATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 125     NORTH AMERICA SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 126     NORTH AMERICA ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 127     NORTH AMERICA SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 128     NORTH AMERICA STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 129     NORTH AMERICA CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 130     NORTH AMERICA PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 131     NORTH AMERICA GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 132     NORTH AMERICA OLEOCHEMICALS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 133     NORTH AMERICA USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 134     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, (2017-2025) ($MN)
      • TABLE 135     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2017-2025) ($MN)
      • TABLE 136     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2017-2025) ($MN)
      • TABLE 137     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2017-2025) ($MN)
      • TABLE 138     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 139     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 140     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 141     EUROPE INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 142     EUROPE CALCIUM SALTS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 143     EUROPE CALCIUM CARBONATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 144     EUROPE METAL OXIDES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 145     EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 146     EUROPE CARBOHYDRATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 147     EUROPE SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 148     EUROPE ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 149     EUROPE SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 150     EUROPE STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 151     EUROPE CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 152     EUROPE PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 153     EUROPE GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 154     EUROPE OLEOCHEMICALS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 155     EUROPE USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 156     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, (2017-2025) ($MN)
      • TABLE 157     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2017-2025) ($MN)
      • TABLE 158     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2017-2025) ($MN)
      • TABLE 159     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2017-2025) ($MN)
      • TABLE 160     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 161     APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 162     APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 163     APAC INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 164     APAC CALCIUM SALTS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 165     APAC CALCIUM CARBONATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 166     APAC METAL OXIDES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 167     APAC ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 168     APAC CARBOHYDRATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 169     APAC SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 170     APAC ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 171     APAC SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 172     APAC STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 173     APAC CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 174     APAC PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 175     APAC GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 176     APAC OLEOCHEMICALS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 177     APAC USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 178     APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, (2017-2025) ($MN)
      • TABLE 179     APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2017-2025) ($MN)
      • TABLE 180     APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2017-2025) ($MN)
      • TABLE 181     APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2017-2025) ($MN)
      • TABLE 182     APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 183     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 184     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 185     ROW INORGANIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 186     ROW CALCIUM SALTS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 187     ROW CALCIUM CARBONATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 188     ROW METAL OXIDES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 189     ROW ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 190     ROW CARBOHYDRATE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 191     ROW SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 192     ROW ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 193     ROW SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 194     ROW STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 195     ROW CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 196     ROW PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 197     ROW GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 198     ROW OLEOCHEMICALS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 199     ROW USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 200     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, (2017-2025) ($MN)
      • TABLE 201     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2017-2025) ($MN)
      • TABLE 202     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2017-2025) ($MN)
      • TABLE 203     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2017-2025) ($MN)
      • TABLE 204     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 205     NEW PRODUCT LAUNCHES (2017-2019)
      • TABLE 206     ACQUISITION (2017-2019)
      • TABLE 207     AGREEMENTS, COLLABORATION & JOINT VENTURES (2017-2019)
      • TABLE 208     ASAHI KASEI: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 209     ASAHI KASEI: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 210     ASAHI KASEI: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 211     ASHLAND, INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 212     ASHLAND, INC.: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 213     ASHLAND, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 214     ASSOCIATED BRITISH FOODS PLC: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 215     ASSOCIATED BRITISH FOODS PLC: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 216     ASSOCIATED BRITISH FOODS PLC: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 217     BASF SE: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 218     BASF SE: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 219     BASF SE: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 220     CRODA INTERNATIONAL PLC: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 221     CRODA INTERNATIONAL PLC: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 222     CRODA INTERNATIONAL PLC: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 223     DOW DUPONT INC. : TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 224     DOW DUPONT INC: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 225     DOW DUPONT INC: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 226     EVONIK INDUSTRIES AG: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 227     EVONIK INDUSTRIES AG: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 228     EVONIK INDUSTRIES AG: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 229     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
      • TABLE 230     MERCK KGAA: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 231     MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)

      LIST OF FIGURES

      • FIGURE 1     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET
      • FIGURE 3     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
      • FIGURE 11     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY MOLECULE TYPE, 2018 (%)
      • FIGURE 12     PHARMACEUTICAL EXCIPIENTS SHARE, USED IN SMALL MOLECULES, 2018 (%)
      • FIGURE 13     PHARMACEUTICAL EXCIPIENTS SHARE, USED IN BIOLOGICS, 2018 (%)
      • FIGURE 14     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE, BY SOURCE (2018 V/S 2025) (%)
      • FIGURE 15     ANIMAL BASED EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 16     PLANT BASED EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 17     MINERAL BASED EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 18     SYNTHETIC BASED EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 19     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE, BY PRODUCT (2018 V/S 2025) (%)
      • FIGURE 20     INORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 21     INORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 22     CALCIUM SALTS EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 23     CALCIUM SALTS EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 24     HALITES EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 25     METALLIC OXIDE EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 26     METALLIC OXIDE EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 27     SILICATES EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 28     OTHER INORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 29     ORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 30     ORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 31     CARBOHYDRATE EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 32     CARBOHYDRATE EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 33     MODIFIED STARCH EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 34     PETROCHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 35     PETROCHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 36     OLEOCHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 37     OLEOCHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 38     PROTEIN EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 39     OTHER ORGANIC CHEMICAL EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 40     PHARMA/USP WATER EXCIPIENTS GLOBAL MARKET SHARE, BY TYPE (2018 V/S 2025) (%)
      • FIGURE 41     PHARMA/USP WATER EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 42     WATER FOR INJECTION EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 43     PURIFIED WATER EXCIPIENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 44     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE, BY MANUFACTURING PROCESS (2018 V/S 2025) (%)
      • FIGURE 45     GRANULATION GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 46     DIRECT COMPRESSION GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 47     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE, BY FUNCTIONALITY (2018 V/S 2025) (%)
      • FIGURE 48     PRESERVATIVE GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 49     SOLVENT GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 50     BINDER & ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 51     FILLERS & DILUENTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 52     SUSPENDING AGENT GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 53     COATING GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 54     SOLUBILIZER GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 55     DISINTEGRANT GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 56     COLORANT, FLAVORING & SWEETENERS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 57     LUBRICANT & GLIDANTS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 58     OTHER GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 59     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE, BY DOSAGE FORMS (2018 V/S 2025) (%)
      • FIGURE 60     SOLID DOSAGE FORMS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 61     INJECTABLES DOSAGE FORMS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 62     SEMI-SOLID, LIQUID & GASEOUS DOSAGE FORMS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 63     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE, BY FINISHED PRODUCTS (2018 V/S 2025) (%)
      • FIGURE 64     PRESCRIPTION DRUGS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 65     OTC DRUGS GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
      • FIGURE 66     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN), CAGR (%)
      • FIGURE 67     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE, BY GEOGRAPHY (2018) (%)
      • FIGURE 68     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY PRODUCT, ORGANIC, INORGANIC AND USP WATER BY TYPE (2018 V/S 2025) (%)
      • FIGURE 69     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY SOURCE, PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) (%)
      • FIGURE 70     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FUNCTION (2018) (%), CAGR (%)
      • FIGURE 71     NORTH AMERICA PHARMACEUTICAL EXCIPIENTS SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 72     U.S. PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 73     U.S. PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 74     U.S. PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 75     REST OF NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 76     REST OF NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 77     REST OF NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 78     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY PRODUCT, ORGANIC, INORGANIC AND USP WATER BY TYPE (2018 V/S 2025) (%)
      • FIGURE 79     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY SOURCE, PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) (%)
      • FIGURE 80     EUROPE PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FUNCTION (2018) (%), CAGR (%)
      • FIGURE 81     EUROPE PHARMACEUTICAL EXCIPIENTS SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 82     GERMANY PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 83     GERMANY PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 84     GERMANY PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 85     FRANCE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 86     FRANCE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 87     FRANCE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 88     ITALY PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 89     ITALY PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 90     ITALY PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 91     REST OF EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 92     REST OF EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 93     REST OF EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 94     APAC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY PRODUCT, ORGANIC, INORGANIC AND USP WATER BY TYPE (2018 V/S 2025) (%)
      • FIGURE 95     APAC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY SOURCE, PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) (%)
      • FIGURE 96     APAC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FUNCTION (2018) (%), CAGR (%)
      • FIGURE 97     APAC PHARMACEUTICAL EXCIPIENTS SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 98     CHINA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 99     CHINA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 100     CHINA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 101     INDIA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 102     INDIA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 103     INDIA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 104     JAPAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 105     JAPAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 106     JAPAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 107     REST OF APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 108     REST OF APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 109     REST OF APAC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 110     ROW PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY PRODUCT, ORGANIC, INORGANIC AND USP WATER BY TYPE (2018 V/S 2025) (%)
      • FIGURE 111     ROW PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY SOURCE, PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) (%)
      • FIGURE 112     ROW PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY FUNCTION (2018) (%), CAGR (%)
      • FIGURE 113     ROW PHARMACEUTICAL EXCIPIENTS SHARE, BY COUNTRY (2018 V/S 2025) (%)
      • FIGURE 114     BRAZIL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 115     BRAZIL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 116     BRAZIL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 117     REST OF LATAM PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 118     REST OF LATAM PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 119     REST OF LATAM PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 120     MIDDLE EAST & OTHERS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE AND PRODUCT (2018 V/S 2025) ($MN)
      • FIGURE 121     MIDDLE EAST & OTHERS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY MANUFACTURING PROCESS, DOSAGE FORMS AND FINISHED PRODUCTS (2018 V/S 2025) ($MN)
      • FIGURE 122     MIDDLE EAST & OTHERS PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTION (2018) ($MN), CAGR (%)
      • FIGURE 123     KEY GROWTH STRATEGIES, (2017-2019)
      • FIGURE 124     SWOT: ASAHI KASEI
      • FIGURE 125     SWOT: ASHLAND INC.
      • FIGURE 126     SWOT: ASSOCIATED BRITISH FOODS PLC (SPI PHARMA)
      • FIGURE 127     SWOT: AVANTOR PERFORMANCE MATERIALS
      • FIGURE 128     SWOT: BASF SE
      • FIGURE 129     SWOT: COLORCON, INC.
      • FIGURE 130     SWOT: CRODA INTERNATIONAL PLC
      • FIGURE 131     SWOT: DFE PHARMA
      • FIGURE 132     SWOT: DOW DUPONT INC.
      • FIGURE 133     SWOT: EVONIK INDUSTRIES AG
      • FIGURE 134     SWOT: LUBRIZOL CORPORATION
      • FIGURE 135     SWOT: MERCK KGAA
      • FIGURE 136     SWOT: ROQUETTE

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     A & C AMERICAN CHEMICALS LIMITED
      • 2     ACCENT MICROCELL PRIVATE LIMITED
      • 3     ACG ASSOCIATED CAPSULES PRIVATE LIMITED
      • 4     AKHIL HEALTHCARE PVT. LTD.
      • 5     ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO., LTD.
      • 6     ARCHER DANIELS MIDLAND COMPANY
      • 7     ARMOR PHARMA
      • 8     ASAHI KASEI CORPORATION
      • 9     ASHA CELLULOSE (I) PVT. LTD.
      • 10     ASHLAND INC.
      • 11     ASSOCIATED BRITISH FOODS PLC
      • 12     AUG. HEDINGER GMBH & CO. KG
      • 13     AVANTOR, INC.
      • 14     BASF SE
      • 15     BENEO
      • 16     BIOGRUND GMBH
      • 17     BRENNTAG AG
      • 18     CARGILL, INCORPORATED
      • 19     CELANESE CORPORATION
      • 20     CHEMFIELD CELLULOSE PVT. LTD.
      • 21     CHEMPILOTS A/S
      • 22     COLORCON INC.
      • 23     CORDENPHARMA INTERNATIONAL
      • 24     COREL PHARMA CHEM
      • 25     CREST CELLULOSE PVT. LTD.
      • 26     CRODA INTERNATIONAL PLC
      • 27     DAFFODIL PHARMA
      • 28     DFE PHARMA
      • 29     DOW DUPONT INC.
      • 30     EASTMAN CHEMICAL COMPANY
      • 31     EVONIK INDUSTRIES AG
      • 32     FINAR LIMITED
      • 33     GANGWAL CHEMICALS PRIVATE LIMITED
      • 34     GATTEFOSSÉ SAS
      • 35     HENGYANG DESEN BIOTECHNOLOGY CO., LTD.
      • 36     HUZHOU ZHANWANG PHARMACEUTICAL CO., LTD.
      • 37     IDEAL CURES PVT. LTD.
      • 38     IMPAG GROUP
      • 39     INGREDION INCORPORATED
      • 40     JAYSONS API PRIVATE LIMITED
      • 41     JD PHARMASCIENCES
      • 42     JRS PHARMA
      • 43     KASYAP SWEETNERS LIMITED
      • 44     KERRY GROUP
      • 45     LACTOSE INDIA LTD.
      • 46     LIAONING OXIRANPHEX INC.
      • 47     LUBRIZOL CORPORATION
      • 48     MAPLE BIOTECH PRIVATE LIMITED
      • 49     MEGGLE PHARMA
      • 50     MERCK MILLIPORE
      • 51     MINERAL TECHNOLOGIES INC.
      • 52     NITIKA PHARMACEUTICALS SPECIALITIES PVT. LTD.
      • 53     OMYA INTERNATIONAL AG
      • 54     PATEL CHEM SPECIALITIES PRIVATE LIMITED
      • 55     PAUSHAK LIMITED
      • 56     PFANSTIEHL INC.
      • 57     RELIANCE CELLULOSE PRODUCTS LIMITED
      • 58     ROQUETTE FRÈRES SA
      • 59     SAUDI KAYAN PETROCHEMICAL COMPANY (SABIC)
      • 60     SAVVY SPECHEMS PRIVATE LIMITED
      • 61     SELECT CHEMIE AG
      • 62     SEPPIC SA
      • 63     SEQENS SAS
      • 64     SHREEJI PHARMA INTERNATIONAL
      • 65     SIGACHI INDUSTRIES PRIVATE LIMITED
      • 66     SIGNET CHEMICAL CORPORATION PRIVATE LIMITED
      • 67     SNA HEALTHCARE PRIVATE LIMITED
      • 68     SOLVAY SA
      • 69     SPECTRUM CHEMICAL MANUFACTURING CORP.
      • 70     STROEVER GMBH & CO. KG
      • 71     SUDEEP PHARMA PVT. LTD.
      • 72     SURFACHEM GROUP LTD.
      • 73     TEREOS SA
      • 74     VALTRIS SPECIALTY CHEMICAL
      • 75     VENATOR MATERIALS PLC
      • 76     VIKAASH CHEMICALS
      • 77     VIKRAM THERMO LTD.
      • 78     WACKER CHEMIE AG
      • 79     W. R. GRACE & CO.-CONN.
      • 80     XIAMEN SHENGLANG SAICHUANG BIOLOGICAL TECHNOLOGY CO.
      • 81     ZUCHEM INC.